Abujamous, L., Soltani, A., Al-Thawadi, H., & Agouni, A. (2024). Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer. Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina.
Chicago Style (17th ed.) CitationAbujamous, Lama, Abderrezzaq Soltani, Hamda Al-Thawadi, and Abdelali Agouni. Advances in Nanotechnology-enabled Drug Delivery for Combining PARP Inhibitors and Immunotherapy in Advanced Ovarian Cancer. Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina, 2024.
MLA引文Abujamous, Lama, et al. Advances in Nanotechnology-enabled Drug Delivery for Combining PARP Inhibitors and Immunotherapy in Advanced Ovarian Cancer. Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina, 2024.